| Literature DB >> 25635834 |
Xianyong Ma1, Chuntian Zheng1, Youjun Hu1, Li Wang1, Xuefen Yang1, Zongyong Jiang1.
Abstract
Forty-eight Duroc x Landrace x Large White gilts were used to determine the relationship between proteome changes of longissimus muscle and intramuscular fat (IMF) content in arginine-supplemented pigs. Beginning at 60 kg BW, pigs were fed a corn- and soybean meal-based diet supplemented or not with 1% L-arginine until they reached a BW of 100 kg. Supplementation with 1% L-arginine did not affect the growth performance or carcass traits, while it increased IMF content by 32% (P < 0.01), it also decreased the drip loss at 48 h post-mortem and the b* meat color value at 24 h post-mortem; supplementation with 1% dietary L-arginine did not change the proportion of SFA and MUFA in muscle lipids. The proteome changes in longissimus muscle between the control and supplemented pigs showed that L-arginine significantly influenced the abundance of proteins related to energy metabolism, fiber type and structure. The increase in IMF content was positively correlated with the increased abundance of slow twitch troponin I (TNNI1) protein and negatively correlated with myosin heavy chain IIb (MyHC IIb) protein content. It is suggested that the proteome changes in longissimus muscle contributed to the greater IMF content in L-arginine supplemented pigs.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25635834 PMCID: PMC4311982 DOI: 10.1371/journal.pone.0117294
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Formulation and nutrient content of diets.
| Diet ingredients (% by weight) | Control | Arginine Supplemented |
|---|---|---|
| Corn meal | 72.7 | 73.1 |
| Soybean meal | 17.6 | 17.6 |
| Wheat bran | 3 | 3 |
| Rape meal | 4 | 4 |
| Alanine | 1.4 | 0 |
| Arginine | 0 | 1 |
| Premix | 1 | 1 |
| L-lysine HCl | 0.12 | 0.12 |
| Limestone | 1 | 1 |
| Salt | 0.3 | 0.3 |
| Dicalcium phosphate | 0.3 | 0.3 |
| Total | 101.42 | 101.42 |
| Digestible energy (Mcal/kg) | 3.23 | 3.23 |
| CP (%) | 15.51 | 15.51 |
| Lys (%) | 0.80 | 0.80 |
| Met (%) | 0.24 | 0.24 |
| Met+Cys (%) | 0.51 | 0.51 |
| Thr (%) | 0.58 | 0.58 |
| Trp (%) | 0.17 | 0.17 |
| Arg(%) | 0.96 | 1.96 |
| Valine(%) | 0.71 | 0.71 |
| Ca (%) | 0.55 | 0.55 |
| Total P (%) | 0.42 | 0.42 |
| Available P (%) | 0.19 | 0.19 |
| Na (%) | 0.15 | 0.15 |
| Cl (%) | 0.24 | 0.24 |
*Premix contained 1750 IU/kg vitamin A, 220 IU/kg vitamin D3, 3 IU/kg vitamin E, 0.55 mg/kg vitamin K3, 0.25 mg/kg vitamin B1, 1.0 mg/kg vitamin B2, 0.7 mg/kg vitamin B6, 3 μg/kg vitamin B12, 4 mg/kg niacin, 1.6 mg/kg calcium pantothenate, 0.1 mg/kg folic acid, 7 μg/kg biotin, 0.08 g/kg choline chloride, 6.5 mg/kg Mn, 15mg/kg Fe, 15 mg/kg Zn, 1.5 mg/kg copper (Cu), 0.07 mg/kg iodine (I2), 0.03 mg/kg selenium (Se), and 1 g/kg sodium chloride (NaCl).
Effect of dietary L-arginine supplementation on growth performance
| Variable | Control | 1% arginine | |
|---|---|---|---|
| ADG (kg) | 0.79 ± 0.03 | 0.77 ± 0.02 | |
| ADFI (kg) | 2.69 ± 0.10 | 2.69 ± 0.05 | |
| F:G | 3.43 ± 0.08 | 3.50 ± 0.07 | |
| Loin eye area (mm2) | 5375 ± 258 | 5459 ± 87 | |
| Backfat depth (cm) | First rib | 4.00 ± 0.12 | 3.88 ± 0.34 |
| Tenth rib | 2.07 ± 0.20 | 1.99 ± 0.14 | |
| Last rib | 1.27 ± 0.06 | 1.20 ± 0.09 | |
Data are means ± SEM, n = 24. There were no significant effects of supplementation (P > 0.05).
ADG average daily gain, ADFI average daily feed intake, F:G feed to gain ratio.
Effect of dietary L-arginine supplementation on indices of meat quality.
| Variable | Control | 1% arginine | ||
|---|---|---|---|---|
| pH | 45 min | 6.50 ± 0.06 | 6.57 ± 0.06 | |
| 24 h | 5.57 ± 0.06 | 5.65 ± 0.06 | ||
| Drip loss (%) | 24 h | 1.21 ± 0.05 | 1.02 ± 0.07 | |
| 48 h | 2.32 ± 0.06 | 2.04 ± 0.10* | ||
| Meat color | 45 min | a* | 15.57 ± 0.23 | 15.74 ± 0.25 |
| b* | 2.70 ± 0.20 | 2.60 ± 0.19 | ||
| L | 45.85 ± 0.51 | 45.74 ± 0.48 | ||
| 24 h | a* | 18.03 ± 0.29 | 18.40 ± 0.28 | |
| b* | 7.36 ± 0.36 | 2.63 ± 0.47* | ||
| L | 52.24 ± 0.44 | 51.71 ± 1.17 | ||
| Shear force(Nf) | 46.03 ± 1.86 | 43.04 ± 1.21 | ||
| Intramuscular fat (%) | 3.96 ± 0.41 | 5.23 ± 0.35** | ||
Data are means ± SEM, n = 24. Within a row, means with * indicate a significant difference (P < 0.05), means with ** indicate a significant difference (P < 0.01).
L, lightness; a*, redness; b*, yellowness.
Effect of L-arginine on fatty acid composition in longissimus muscle.
| Fatty acid | Control | 1% arginine |
|---|---|---|
| C14:0 | 1.71 ± 0.19 | 1.65 ± 0.15 |
| C15:0 | 0.03 ± 0.008 | 0.03± 0.008 |
| C16:0 | 24.50 ± 0.90 | 23.12 ± 0.78 |
| C16:1 | 4.25 ± 0.46 | 4.32 ± 0.71 |
| C17:0 | 0.19 ± 0.04 | 0.17 ± 0.04 |
| C17:1 | 0.25 ± 0.05 | 0.23 ± 0.04 |
| C18:0 | 14.56 ± 0.49 | 15.46 ± 0.96 |
| C19:0 | 0.06 ± 0.01 | 0.05 ± 0.01 |
| C18:1 | 44.97 ± 0.78 | 44.64 ± 1.77 |
| C18:2 | 7.08 ± 0.37 | 7.76 ± 0.11 |
| C18:3 | 0.27 ± 0.04 | 0.31 ± 0.02 |
| C20:0 | 0.24 ± 0.04 | 0.27 ± 0.04 |
| C20:1 | 0.86 ± 0.08 | 1.11 ± 0.10** |
| C20:2 | 0.36 ± 0.06 | 0.33 ± 0.03 |
| C20:3 | 0.10 ± 0.02 | 0.09 ± 0.02 |
| C20:4 | 0.40 ± 0.03 | 0.39± 0.05 |
| C22:6 | 0.15 ± 0.06 | 0.39± 0.06* |
| SFA | 41.23± 1.64 | 40.75 ± 1.98 |
| MUFA | 50.33 ± 1.37 | 50.30 ± 2.62 |
| PUFA | 8.36 ± 0.58 | 9.27 ± 0.30* |
Data are means of fatty acid percentages ± SEM, n = 24.
Within a row, means with * indicate a significant difference (P < 0.05), means with ** indicate a significant difference (P < 0.01).
SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids.
Effect of dietary L-arginine on the diameter and density of adipocytes in longissimus muscle.
| Indices | Control | 1% arginine |
|---|---|---|
| Diameter (μm) | 128.14 ± 4.42 | 132.50 ± 3.42 |
| Density (cells/mm2) (*102) | 8.09 ± 1.39 | 10.62 ± 1.85 |
Data are means ± SEM, n = 24. There were no significant effects of supplementation (P < 0.05).
Effect of dietary arginine supplementation on blood variables.
| Indexes | Control | 1% arginine |
|---|---|---|
| HDL (mmol/L) | 1.08 ± 0.04 | 1.13 ± 0.05 |
| LDL (mmol/L) | 1.05 ± 0.05 | 1.05 ± 0.05 |
| Cholesterol (mmol/L) | 2.15 ± 0.09 | 2.17 ± 0.08 |
| Triglycerol (mmol/L) | 0.45 ± 0.08 | 0.43 ± 0.07 |
| Glucose (mmol/L) | 167.96 ± 7.58 | 157.13 ± 8.23 |
| Leptin (ng/ml) | 0.76 ± 0.12 | 0.79 ± 0.17 |
Data are means ± SEM, n = 24. There were no significant effects of supplementation (P < 0.05). HDL, high density lipoproteins, LDL, low density lipoproteins
Fig 1Representative 2-DE images of longissimus muscle samples.
2-DE was per-formed using a pH range of 3–10 in the first dimension and SDS-PAGE (12%) in the second. Control sample is shown at the left and sample from 1% arginine supplementation is shown at the right. Detected protein spots are marked with red “+” and protein abundances that differ significantly between control and supplemented pigs are assigned numbers, corresponding to Table 7. MW, Molecular weight; PI, Isoelectric point.
Longissimus proteins differentially expressed between control and arginine supplemented pigs.
| No | Identified protein | Accession No | Protein MW / pI | Best Ion Score | Intensity matched | Fold Change | P- value |
|---|---|---|---|---|---|---|---|
| 1 | Muscle creatine kinase( | gi|194018722 | 43031 / 6.61 | 47 | 89.74 | 0.41 | 0.015 |
| 2 | Muscle creatine kinase( | gi|194018722 | 43031 / 6.61 | 52 | 88.25 | 0.53 | 0.001 |
| 3 | Actin-α1( | gi|27819614 | 41919 / 5.30 | 41 | 64.50 | 0.61 | 0.001 |
| 4 | Slow-twitch skeletal troponin I (TNNI1) ( | gi|339965 | 21648 / 9.55 | 45 | 67.05 |
| |
| 5 | Muscle creatine kinase( | gi|194018722 | 43031 / 6.61 | 62 | 87.68 | 0.54 | 0.001 |
| 6 | Slow-twitch skeletal troponin I (TNNI1) ( | gi|339965 | 21648 / 9.55 | 45 | 67.05 |
| |
| 7 | Muscle glycogen phosphorylase ( | gi|57163939 | 97245 / 6.65 | 25 | 51.79 | 0.36 | 0.031 |
| 8 | Muscle glycogen phosphorylase( | gi|57163939 | 97245 / 6.65 | 114 | 69.03 | 0.49 | 0.003 |
| 9 | LIM domain binding 3( | gi|122056619 | 30979 / 9.2 | 88 | 46.08 | 0.42 | 0.007 |
| 10 | Actinin alpha 3 ( | gi|7304855 | 102977 / 5.31 | 31 | 65.36 |
| |
| 11 | Muscle creatine kinase( | gi|194018722 | 43031 / 6.61 | 68 | 83.07 | 0.55 | 0.002 |
| 12 | Phosphoglycerate kinase 1 ( | gi|153792027 | 44530 / 8.02 | 30 | 70.85 | 0.55 | 0.001 |
| 13 | Myosin heavy chain 2b( | gi|178056718 | 223097 / 5.6 | 33 | 56.65 | 0.51 | 0.007 |
| 14 | Cytosolic malate dehydrogenase ( | gi|47523114 | 36431 / 6.16 | 43 | 77.53 | 0.49 | 0.002 |
| 15 | Peroxiredoxin 6( | gi|47523870 | 25021 / 5.73 | 25 | 85.38 | 0.34 | 0.007 |
| 16 | Muscle creatine kinase( | gi|194018722 | 43031 / 6.61 | 57 | 88.38 | 0.50 | 0.005 |
| 17 | Muscle-specific enolase β-subunit ( | gi|34789 | 46929 / 7.59 | 51 | 51.56 | 0.47 | 0.003 |
| 18 | PDZ and LIM domain7 | gi|29436855 | 21083 / 9.66 | 61 | 58.01 | 0.41 | 0.001 |
1 corresponding to numbers in Fig. 1,
* L-arginine supplemented/control,
# only detected in the supplemented samples.
Fig 2Western-blots for a selection of differentially-expressed proteins.
MyH2b, TNNI1 and MCK were used as target protein; GADPH was used as a control. A: Total protein from control and arginine-supplemented pig samples was fractionated by SDS-PAGE, blotted and then detected with specific antibodies; B: Semi-quantification of protein content computed using Image J software. Data are presented as the mean ±SEM (n = 6).